180 related articles for article (PubMed ID: 9816124)
1. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes.
Sandoval A; Consoli U; Plunkett W
Clin Cancer Res; 1996 Oct; 2(10):1731-41. PubMed ID: 9816124
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of repair of carboplatin-induced DNA damage by 9-beta-D-arabinofuranosyl-2-fluoroadenine in quiescent human lymphocytes.
Takagi K; Kawai Y; Yamauchi T; Ueda T
Biochem Pharmacol; 2004 Nov; 68(9):1757-66. PubMed ID: 15450941
[TBL] [Abstract][Full Text] [Related]
3. Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine.
Rao VA; Plunkett W
Clin Cancer Res; 2003 Aug; 9(8):3204-12. PubMed ID: 12912974
[TBL] [Abstract][Full Text] [Related]
4. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Yamauchi T; Nowak BJ; Keating MJ; Plunkett W
Clin Cancer Res; 2001 Nov; 7(11):3580-9. PubMed ID: 11705880
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nucleotide excision repair by fludarabine in normal lymphocytes in vitro, measured by the alkaline single cell gel electrophoresis (Comet) assay.
Yamauchi T; Kawai Y; Ueda T
Jpn J Cancer Res; 2002 May; 93(5):567-73. PubMed ID: 12036453
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.
Li L; Liu X; Glassman AB; Keating MJ; Stros M; Plunkett W; Yang LY
Cancer Res; 1997 Apr; 57(8):1487-94. PubMed ID: 9108450
[TBL] [Abstract][Full Text] [Related]
7. Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary step.
Rodriguez CO; Gandhi V
Cancer Res; 1999 Oct; 59(19):4937-43. PubMed ID: 10519407
[TBL] [Abstract][Full Text] [Related]
8. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
Yang LY; Li L; Keating MJ; Plunkett W
Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
[TBL] [Abstract][Full Text] [Related]
9. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
Huang P; Plunkett W
Mol Pharmacol; 1991 Apr; 39(4):449-55. PubMed ID: 1708088
[TBL] [Abstract][Full Text] [Related]
10. Role of fludarabine in hematological malignancies.
Montillo M; Ricci F; Tedeschi A
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1141-61. PubMed ID: 17020450
[TBL] [Abstract][Full Text] [Related]
11. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
Seymour JF; Huang P; Plunkett W; Gandhi V
Clin Cancer Res; 1996 Apr; 2(4):653-8. PubMed ID: 9816215
[TBL] [Abstract][Full Text] [Related]
12. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
Grégoire V; Van NT; Stephens LC; Brock WA; Milas L; Plunkett W; Hittelman WN
Cancer Res; 1994 Dec; 54(23):6201-9. PubMed ID: 7954467
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.
Gandhi V; Huang P; Chapman AJ; Chen F; Plunkett W
Clin Cancer Res; 1997 Aug; 3(8):1347-55. PubMed ID: 9815818
[TBL] [Abstract][Full Text] [Related]
14. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Van den Neste E; Cardoen S; Offner F; Bontemps F
Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
[TBL] [Abstract][Full Text] [Related]
15. Use of novel plasmid constructs to demonstrate fludarabine triphosphate inhibition of nucleotide excision repair of a site-specific 1,2-d(GpG) intrastrand cisplatin adduct.
Li MJ; Yang LY
Int J Oncol; 1999 Dec; 15(6):1177-83. PubMed ID: 10568825
[TBL] [Abstract][Full Text] [Related]
16. A comet assay study reveals that aluminium induces DNA damage and inhibits the repair of radiation-induced lesions in human peripheral blood lymphocytes.
Lankoff A; Banasik A; Duma A; Ochniak E; Lisowska H; Kuszewski T; Góźdź S; Wojcik A
Toxicol Lett; 2006 Feb; 161(1):27-36. PubMed ID: 16139969
[TBL] [Abstract][Full Text] [Related]
17. Adaptation of the TdT assay for semi-quantitative flow cytometric detection of DNA strand breaks.
Bromidge TJ; Howe DJ; Johnson SA; Phillips MJ
Cytometry; 1995 Jul; 20(3):257-60. PubMed ID: 7587711
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
19. The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage.
Sampath D; Plunkett W
Cancer Res; 2000 Nov; 60(22):6408-15. PubMed ID: 11103806
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Avramis VI; Plunkett W
Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]